Bioactivity:

Cenupatide is a urokinase plasminogen activator receptor (uPAR) inhibitor. Cenupatide inhibits uPAR binding to the formyl peptide receptors (FPRs) can improve kidney lesions in a rat model of STZ-induced diabetes. Cenupatide reverted STZ-induced up-regula

CAS nr:

1006388-38-0

Purity:

98%

Molecular Weight:

845,8

SMILES:

O=C(NC(C)(C)C(N[C@@H](CCCNC(N)=N)C(N[C@](CC1=CC=CC=C1)(C)C(N)=O)=O)=O)[C@@H](NC(C)=O)CCCNC(N)=N.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F

Formula:

C32H49F6N11O9

Pathway:

Target: